Weight Loss Not Enough to Sustain T2D Remission Weight Loss Not Enough to Sustain T2D Remission
Only about 6% of study participants achieved and sustained normal blood glucose levels with weight loss alone.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 24, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
SGLT2 Inhibitors Protective Against Retinopathy in T2D SGLT2 Inhibitors Protective Against Retinopathy in T2D
SGLT2 inhibitors are known to reduce diabetic nephropathy risk in patients with type 2 diabetes, but can they also protect against diabetic retinopathy?Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 23, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
' Real Progress' in Recommendations for Treating T2D'Real Progress' in Recommendations for Treating T2D
The ADA Standards of Care in Diabetes –2024 makes progress in managing type 2 diabetes, but Dr Anne Peters ponders whether it ' s fast enough. (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 22, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Type 2 Diabetes Remission Linked to Lower CKD, CVD Risk Type 2 Diabetes Remission Linked to Lower CKD, CVD Risk
Look AHEAD trial participants who achieved type 2 diabetes remission had lower risks for CKD and CVD, in a dose-response relationship by remission duration.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 22, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Testosterone Increases Fracture Risk in Hypogonadal Men? Testosterone Increases Fracture Risk in Hypogonadal Men?
Though testosterone treatment improves bone strength and structure, a large study on older hypogonadal men showed a high risk for fracture with the treatment.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 19, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Pledging to End Diabetes Stigma and Discrimination Pledging to End Diabetes Stigma and Discrimination
Multinational joint consensus statement summarized current evidence on diabetes stigma and discrimination and made recommendations for stakeholders including healthcare providers.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 19, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Testosterone Supplements: Overcoming Current Misconceptions Testosterone Supplements: Overcoming Current Misconceptions
About one fifth of patients with symptomatic testosterone deficiency receive treatment, partly because of misconceptions about the risks for therapy.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 18, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Ozempic Is Appealing, but Not Cost-Effective, for Obesity Ozempic Is Appealing, but Not Cost-Effective, for Obesity
Ozempic may not yet be cost-effective, according to a modeling study that compared the drug with surgery.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 18, 2024 Category: Endocrinology Tags: Gastroenterology Source Type: news
Help T1 Diabetes Patients Maximize the Benefits of Exercise Help T1 Diabetes Patients Maximize the Benefits of Exercise
A few simple precautions can help prevent hypoglycemia.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Nonprescription Weight Loss Product Use Common Among Adolescents Nonprescription Weight Loss Product Use Common Among Adolescents
Prevalence of nonprescription diet pills use among adolescents rises as social media influences become more aggressive than ever.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Prostate Risks Similar for Testosterone Therapy and Placebo Prostate Risks Similar for Testosterone Therapy and Placebo
For men with hypogonadism and low prostate cancer risk, TRT didn ' t increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
' Subtle Changes' to the 2024 ADA Standards of Care'Subtle Changes' to the 2024 ADA Standards of Care
Anne Peters, MD, provides an overview of the updates to the ADA Standards of Care in Diabetes.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 16, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news
Direct Measurement of T3 Is Likely Vital, Say Researchers Direct Measurement of T3 Is Likely Vital, Say Researchers
" It is important to note that the more typically measured biomarkers for thyroid function (T4 and TSH) are poorly linked to free T3 levels, " said researchers.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 15, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Gestational Diabetes May Double Chronic Kidney Disease Risk Gestational Diabetes May Double Chronic Kidney Disease Risk
Gestational diabetes raises the risk for future chronic kidney disease, a risk heightened by subsequent diabetes or hypertension, found an analysis of Danish registry data.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 15, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Why Do GLP-1 Drugs Stop Working, and What to Do About It? Why Do GLP-1 Drugs Stop Working, and What to Do About It?
Everybody has a set point, and every weight loss intervention eventually leads to a plateau, so it helps to have a variety of tools to support patients.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
